Scenario name,Rate of gonorrhea cases,"% cases successfully treated with CIP, TET, or CRO",% cases susceptible to CIP,% cases susceptible to TET,% cases susceptible to CRO,"Effective lifespan of CIP, TET, and CRO",Effective lifespan of CIP,Effective lifespan of TET,Effective lifespan of CRO,delta - Rate of gonorrhea cases,"delta - Effective lifespan of CIP, TET, and CRO",delta - Effective lifespan of CIP,delta - Effective lifespan of TET,delta - Effective lifespan of CRO
Status quo (no rapid test),"6,775 (4,802, 8,751)","37.2% (30.4%, 42.6%)","70.2% (57.8%, 83.2%)","16.3% (12.6%, 23.4%)","94.6% (91.4%, 96.0%)","13.0 (10.6, 14.9)","24.6 (20.2, 29.1)","5.7 (4.4, 8.2)","33.1 (32.0, 33.6)",,,,,
"(p=None, None), q=(None, None), c=0.500)","7,085 (5,064, 9,134)","45.0% (36.8%, 57.4%)","65.1% (52.9%, 80.5%)","14.5% (11.2%, 21.8%)","95.6% (93.8%, 96.9%)","15.8 (12.9, 20.1)","22.8 (18.5, 28.2)","5.1 (3.9, 7.6)","33.5 (32.8, 33.9)","4.7% (1.3%, 9.2%)","21.1% (3.3%, 46.1%)","-7.4% (-12.7%, -3.0%)","-11.3% (-17.2%, -3.9%)","1.0% (-1.8%, 3.7%)"
"(p=None, None), q=(None, None), c=0.750)","7,267 (5,260, 9,359)","45.2% (36.8%, 57.4%)","63.5% (51.2%, 78.2%)","13.9% (10.6%, 21.0%)","95.4% (92.6%, 96.7%)","15.8 (12.9, 20.1)","22.2 (17.9, 27.4)","4.9 (3.7, 7.4)","33.4 (32.4, 33.8)","7.5% (2.8%, 12.3%)","21.4% (3.4%, 37.6%)","-9.8% (-15.8%, -5.1%)","-14.9% (-22.3%, -6.4%)","0.8% (-1.2%, 4.0%)"
"(p=None, None), q=(None, None), c=1.000)","7,474 (5,429, 9,698)","45.9% (36.9%, 57.4%)","62.0% (49.8%, 79.3%)","13.2% (10.2%, 20.3%)","95.3% (94.0%, 96.8%)","16.1 (12.9, 20.1)","21.7 (17.4, 27.8)","4.6 (3.6, 7.1)","33.3 (32.9, 33.9)","10.6% (2.7%, 18.3%)","23.5% (3.6%, 41.1%)","-11.9% (-20.5%, -3.9%)","-19.2% (-27.7%, -7.3%)","0.7% (-1.3%, 3.3%)"
